Terms: = Brain cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Prognosis
10 results:
1. Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M
Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082
[TBL] [Abstract] [Full Text] [Related]
2. Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/klf4 pathway.
Gong M; Wang X; Mu L; Wang Y; Pan J; Yuan X; Zhou H; Xing J; Wang R; Sun J; Liu Q; Zhang X; Wang L; Chen Y; Pei Y; Li S; Liu L; Zhao Y; Yuan Y
Cancer Sci; 2021 Feb; 112(2):604-618. PubMed ID: 33090636
[TBL] [Abstract] [Full Text] [Related]
3. Associations of meningioma molecular subgroup and tumor recurrence.
Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
[TBL] [Abstract] [Full Text] [Related]
4. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.
Takenaka MC; Gabriely G; Rothhammer V; Mascanfroni ID; Wheeler MA; Chao CC; Gutiérrez-Vázquez C; Kenison J; Tjon EC; Barroso A; Vandeventer T; de Lima KA; Rothweiler S; Mayo L; Ghannam S; Zandee S; Healy L; Sherr D; Farez MF; Prat A; Antel J; Reardon DA; Zhang H; Robson SC; Getz G; Weiner HL; Quintana FJ
Nat Neurosci; 2019 May; 22(5):729-740. PubMed ID: 30962630
[TBL] [Abstract] [Full Text] [Related]
5. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [
Laws MT; Bonomi RE; Kamal S; Gelovani DJ; Llaniguez J; Potukutchi S; Lu X; Mangner T; Gelovani JG
Sci Rep; 2019 Mar; 9(1):3595. PubMed ID: 30837601
[TBL] [Abstract] [Full Text] [Related]
6. Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231.
De Blasio A; Di Fiore R; Morreale M; Carlisi D; Drago-Ferrante R; Montalbano M; Scerri C; Tesoriere G; Vento R
Int J Oncol; 2016 Jun; 48(6):2339-48. PubMed ID: 27082853
[TBL] [Abstract] [Full Text] [Related]
7. The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model.
Yin B; Ma ZY; Zhou ZW; Gao WC; Du ZG; Zhao ZH; Li QQ
Oncogene; 2015 Feb; 34(6):761-70. PubMed ID: 24531713
[TBL] [Abstract] [Full Text] [Related]
8. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.
Wang H; Feng Y; Bao Z; Jiang C; Yan W; Wang Y; Zhang C; Liu Y; Zhang Q; Zhang W; Jiang C
Oncol Rep; 2013 Nov; 30(5):2089-96. PubMed ID: 24002581
[TBL] [Abstract] [Full Text] [Related]
10. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating klf4.
Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
[TBL] [Abstract] [Full Text] [Related]
